Genomics

Dataset Information

0

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection


ABSTRACT: The aim of this deep sequencing project is to determine whether treatment of chronically Hepatitis C infected chimpanzees with an antiviral compound leads to accumulation of viral mutants. The liver-expressed microRNA-122 (miR-122) is essential for hepatitis C virus (HCV) RNA accumulation in cultured liver cells, but its potential as a target for antiviral intervention has not been assessed. Here, we show that treatment of chronically infected chimpanzees with a locked nucleic acid (LNA)-modified oligonucleotide (SPC3649) complementary to miR-122 leads to long-lasting suppression of HCV viremia with no evidence for viral resistance or side effects in the treated animals. Furthermore, transcriptome and histological analyses of liver biopsies demonstrated derepression of target mRNAs with miR-122 seed sites, down-regulation of interferon-regulated genes (IRGs) and improvement of HCV-induced liver pathology. The prolonged virological response to SPC3649 treatment without HCV rebound holds promise of a new antiviral therapy with a high barrier to resistance.

ORGANISM(S): Hepacivirus hominis

PROVIDER: GSE18919 | GEO | 2009/12/03

SECONDARY ACCESSION(S): PRJNA121271

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-04-24 | PXD013054 | Pride
2014-12-18 | GSE57381 | GEO
2014-12-18 | E-GEOD-57381 | biostudies-arrayexpress
2015-01-06 | GSE64679 | GEO
2015-01-06 | GSE64678 | GEO
2015-01-06 | GSE64677 | GEO
2015-01-06 | GSE64676 | GEO
2015-01-06 | GSE64675 | GEO
2015-01-06 | E-GEOD-64677 | biostudies-arrayexpress
2011-03-09 | GSE27850 | GEO